HealthcareNewsTravel

Global Epigenetics Market Industry Analysis, Size, Share, Growth, Trends, and Forecast By Thermo Fisher Scientific Inc.; Cellcentric; Syndax; New England Biolabs; Epizyme, Inc.; Domainex; Agilent Technologies, Inc

Epigenetics report gives information about the competitive situation among the market vendors and company profile. The market research performed over here was provided for leading growth status, including developments, segmentation, landscape analysis, product types and applications. The data and information on market size, market share and growth rate as well as industry analysis across different regions makes this report a wonderful resource for business players. This Epigenetics market research report has gone through the proper research methodology and is validated from the professionals and analysts to ensure the eminent quality reports before presenting it to the users.

Get Sample Copy Of This Report @  https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-epigenetics-market

Few of the major competitors currently working in the global epigenetics market are Illumina, Inc.; Merck KGaA; QIAGEN; F. Hoffmann-La Roche Ltd; Eisai Co., Ltd.; Novartis AG; Abcam plc; Diagenode s.a.; Active Motif; Zymo Research; Thermo Fisher Scientific Inc.; Cellcentric; Syndax; New England Biolabs; Epizyme, Inc.; Domainex; Agilent Technologies, Inc.; PerkinElmer Inc.; Bio-Rad Laboratories, Inc.; AsisChem Inc.; Enzo Life Sciences, Inc.; EpiGentek Group Inc.; BioVision Inc.; Bio-Techne; Promega Corporation; GeneTex, Inc. and Pacific Biosciences of California, Inc. among others.

Key Developments in the Market:

  • In May 2019, Souvien Therapeutics was established by Juvenescence, which will focus on development of innovative medicines for applications in neurodegenerative disorders with the help of targeting epigenetics in neurodegeneration. The company will focus on development of therapeutics to address the epigenetics mechanisms in neurodegenerations
  • In May 2018, Cellcentric announced that they had raised USD 26 million for the development of epigenetic based drug candidate for cancers till the stage of Phase 2B trials. The drug termed as, “CCS1477” has been evident to treat patients suffering from late-stage prostate cancer, being resistance against anti-androgen drugs. Cellcentric is aiming to increase its application of the drug candidate to more than just prostate cancer where the cancer is showing mutation signs of p300 and CBP proteins

Table Of Content:

Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Global Epigenetics Market Landscape

Part 04: Global Epigenetics Market Sizing

Part 05: Global Epigenetics Market Segmentation By Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape
Part 08: Geographic Landscape

Part 09: Decision Framework
Part 10: Drivers And Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

Get Detailed Table Of Content @  https://www.databridgemarketresearch.com/toc/?dbmr=global-epigenetics-market

Segmentation: Global Epigenetics Market

By Product

(Reagents, Kits & Assays, Instruments, Enzymes, Services, Bioinformatics Tools),

Technology

(DNA Methylation, Histone Methylation, Histone Acetylation, Large Non-Coding RNA, MicroRNA Modification, Chromatin Structures),

Application

(Oncology, Non-Oncology, Developmental Biology, Drug Discovery, Others),

End-Users

(Academic & Research Institutes, Pharmaceutical Companies, Biotechnology Companies, CROs),

Geography

(North America, Europe, Asia-Pacific, South America, Middle East and Africa)

Need more Information about Report Methodology @    https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-epigenetics-market

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]

Tags

>

Related Articles

Back to top button